Systematic review of the efficacy, effectiveness and safety of cell-based seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age.

Autor: Jordan K; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland., Murchu EO; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland.; Department of Health Policy & Management, School of Medicine, Trinity College Dublin, Dublin, Ireland., Comber L; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland., Hawkshaw S; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland., Marshall L; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland., O'Neill M; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland., Teljeur C; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland., Harrington P; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland., Carnahan A; Public Health Agency of Sweden, Solna, Sweden.; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden., Pérez-Martín JJ; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; General Directorate of Public Health and Addictions, IMIB-Arrixaca, Murcia University, Murcia, Spain., Robertson AH; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway., Johansen K; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; European Centre for Disease Prevention and Control, Stockholm, Sweden., Jonge J; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Krause T; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; Statens Serum Institut, Copenhagen, Denmark., Nicolay N; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; European Centre for Disease Prevention and Control, Stockholm, Sweden., Nohynek H; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; Finnish Institute for Health and Welfare, Helsinki, Finland., Pavlopoulou I; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; School of Health Sciences, Faculty of Nursing, Pediatric Research Laboratory, National and Kapodistrian University of Athens, Athens, Greece.; National Advisory Committee on Immunisation, Hellenic Ministry of Health, Athens, Greece., Pebody R; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; Institute of Epidemiology & Health, University College London, London, UK., Penttinen P; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; European Centre for Disease Prevention and Control, Stockholm, Sweden., Soler-Soneira M; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; Vigilancia de Enfermedades Prevenibles por Vacunación, Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, Madrid, Spain., Wichmann O; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; Immunization Unit, Robert Koch-Institute, Berlin, Germany., Ryan M; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland.; Department of Pharmacology & Therapeutics, Trinity College Dublin, Trinity. Health Sciences, Dublin, Ireland.

Publikováno v: Reviews in medical virology [Rev Med Virol] 2023 May; Vol. 33 (3), pp. e2332. Date of Electronic Publication: 2022 Feb 08.

Sexual behavior is linked to changes in gut microbiome and systemic inflammation that lead to HIV-1 infection in men who have sex with men.

Autor: Lin, Huang^1,2 (AUTHOR), Chen, Yue³ (AUTHOR), Abror-Lacks, Grace⁴ (AUTHOR), Price, Meaghan⁴ (AUTHOR), Morris, Alison⁵ (AUTHOR), Sun, Jing⁶ (AUTHOR), Palella, Frank⁷ (AUTHOR), Chew, Kara W.⁸ (AUTHOR), Brown, Todd T.⁹ (AUTHOR), Rinaldo, Charles R.³ (AUTHOR) rinaldo@pitt.edu, Peddada, Shyamal D.¹ (AUTHOR) peddada@nih.gov

Publikováno v: Communications Biology. 9/14/2024, Vol. 7 Issue 1, p1-11. 11p.

Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort.

Autor: van den Elshout, Mark A. M.¹ (AUTHOR) mvdelshout@ggd.amsterdam.nl, Wijstma, Eline S.¹ (AUTHOR), Boyd, Anders^1,2,3,4 (AUTHOR), Jongen, Vita W.^1,2 (AUTHOR), Coyer, Liza¹ (AUTHOR), Anderson, Peter L.⁵ (AUTHOR), Davidovich, Udi^1,6 (AUTHOR), de Vries, Henry J. C.^1,3,7 (AUTHOR), Prins, Maria^1,3,4 (AUTHOR), Schim van der Loeff, Maarten F.^1,3,4 (AUTHOR), Hoornenborg, Elske¹ (AUTHOR)

Publikováno v: PLoS Medicine. 5/8/2024, Vol. 21 Issue 5, p1-20. 20p.

Les pièges des rectites.

Autor: Pommaret, Élise¹ (AUTHOR) epommaret@yahoo.fr, Barré, Amélie¹ (AUTHOR), Parades, Vincent¹ (AUTHOR)

Publikováno v: Hépato-Gastro & Oncologie Digestive. may2024, Vol. 31 Issue 5, p495-498. 4p.

Examining Provider Attitudes and Barriers toward Prescribing PrEP within Primary Care Settings in Alabama.

Autor: McNellage, Landon, Snyder, Erin D., Gravett, Ronnie M., Van Gerwen, Olivia T.

Publikováno v: Southern Medical Journal; Dec2024, Vol. 117 Issue 12, p709-714, 6p